← SageRanks

Fisher on the GRANOLAS

This ranking weighs Revenue growth ×4, Analyst upside ×3, Buy % ×2, Gross margin ×2, and nothing else, across the 11 companies we track on the GRANOLAS. Fisher set no numeric limits at all, so no company here is ever flagged: his fifteen points are qualitative.

Ranked highest by Fisher on this market right now, which is not the same list as the one that clears the limits above:

  1. AstraZeneca (AZN) · Healthcare · Revenue growth 6.4% · Analyst upside 33.1% · Buy % 90% · Gross margin 82%
  2. ASML (ASML) · Technology · Revenue growth 21.3% · Analyst upside 28.4% · Buy % 89% · Gross margin 53%
  3. SAP (SAP) · Technology · Revenue growth 9.4% · Analyst upside 20.1% · Buy % 81% · Gross margin 74%
  4. Sanofi (SNY) · Healthcare · Revenue growth 14.6% · Analyst upside 25.7% · Buy % 50% · Gross margin 73%
  5. L'Oréal (LRLCY) · Consumer Defensive · Revenue growth 5.8% · Analyst upside 18.7% · Buy % 75% · Gross margin 74%

From data as of 2026-09-11 01:00:55 UTC. Rebuilt every hour; the table above is live.

All 11 companies on the GRANOLAS, ranked by Fisher, as text
  1. AstraZeneca (AZN) · Revenue growth 6.4% · Analyst upside 33.1% · Buy % 90% · Gross margin 82%
  2. ASML (ASML) · Revenue growth 21.3% · Analyst upside 28.4% · Buy % 89% · Gross margin 53%
  3. SAP (SAP) · Revenue growth 9.4% · Analyst upside 20.1% · Buy % 81% · Gross margin 74%
  4. Sanofi (SNY) · Revenue growth 14.6% · Analyst upside 25.7% · Buy % 50% · Gross margin 73%
  5. L'Oréal (LRLCY) · Revenue growth 5.8% · Analyst upside 18.7% · Buy % 75% · Gross margin 74%
  6. GSK (GSK) · Revenue growth 5.3% · Analyst upside 21.7% · Buy % 14% · Gross margin 73%
  7. Novartis (NVS) · Revenue growth 0.8% · Analyst upside 14.8% · Buy % 42% · Gross margin 75%
  8. Novo Nordisk (NVO) · Revenue growth 2.1% · Analyst upside 7.2% · Buy % 29% · Gross margin 82%
  9. Roche (RHHBY) · Revenue growth -1.2% · Analyst upside 13.6% · Buy % 50% · Gross margin 74%
  10. LVMH (LVMUY) · Revenue growth -2.9% · Analyst upside 30.4% · Buy % 33% · Gross margin 66%
  11. Nestlé (NSRGY) · Revenue growth -2.5% · Analyst upside 16.2% · Buy % 40% · Gross margin 46%